Showing results (501-510 of 526) with videos related to

Sort By:
Pageof 53
Human Mutation|June 22, 2016
Ectrodactyly and Lethal Pulmonary Acinar Dysplasia Associated with Homozygous FGFR2 Mutations Identified by Exome SequencingChristopher P Barnett, Nathalie J Nataren, Manuela Klingler-Hoffmann, et al.
Cancer|September 16, 2006
Asian American Network for Cancer Awareness, Research, and Training's legacy. The first 5 yearsMoon S Chen, Susan M Shinagawa, Dileep G Bal, et al.
Ophthalmology|June 1, 1980
Helium ion charged particle therapy for choroidal melanomaD H Char, J R Castro, J M Quivey, et al.
Msystems|October 31, 2019
Changes in the Composition of the Gut Microbiota and the Blood Transcriptome in Preterm Infants at Less than 29 Weeks Gestation Diagnosed with Bronchopulmonary DysplasiaFeargal J Ryan, Damian P Drew, Chloe Douglas, et al.
BMJ Open|February 7, 2021
Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trialJacqueline F Gould, Maria Makrides, Thomas R Sullivan, et al.
Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.
Cancer Research|June 11, 1999
Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2011
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vectorDawn E Bowles, Scott W J McPhee, Chengwen Li, et al.
Human Gene Therapy|November 25, 2014
Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trialPaul E Monahan, Junjiang Sun, Tong Gui, et al.
BMJ Open|March 20, 2015
Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trialCarmel T Collins, Robert A Gibson, Peter J Anderson, et al.
Pageof 53